ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Non-Small-Cell Lung Cancer trials near Berlin, BE, DEU:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a
Drug: Docetaxel

Phase 3

Daiichi Sankyo

Berlin, Germany and 205 other locations

PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Paclitaxel

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Berlin, Germany and 126 other locations

NSCLC comprises of approximately 84 percent (%) of all lung cancers and is often diagnosed at advanced stage due to poor prognosis....

Active, not recruiting
Lung Cancer, Non-Small Cell
Drug: Chemotherapy
Drug: Dostarlimab

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Berlin, Germany and 57 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 137 other locations

of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...

Active, not recruiting
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Drug: Erlotinib 150/100 mg
Drug: Placebo Erlotinib 150/100mg

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 168 other locations

The research study is testing the investigational drug necitumumab (IMC-11F8) in the treatment of advanced non-small cell ...

Active, not recruiting
Non Small Cell Lung Cancer
Biological: Necitumumab
Drug: Gemcitabine

Phase 3

Lilly
Lilly

Berlin, Germany and 181 other locations

Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...

Enrolling
Non Small Cell Lung Cancer
Biological: Telisotuzumab Vedotin
Drug: Docetaxel

Phase 3

AbbVie
AbbVie

Berlin, Germany and 260 other locations

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Berlin, Germany and 252 other locations

provides improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-sm ...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: CC-486

Phase 2

Celgene
Celgene

Berlin, Germany and 32 other locations

in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells [TC]/ Tumor proportion score [TPS] ≥ 50%), previously untreated, u...

Enrolling
Lung Cancer, Non-Small Cell
Drug: Belrestotug
Drug: GSK6097608

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Berlin, Germany and 120 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems